Massimo Moro

2.0k total citations
39 papers, 1.0k citations indexed

About

Massimo Moro is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Massimo Moro has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cancer Research, 18 papers in Molecular Biology and 18 papers in Oncology. Recurrent topics in Massimo Moro's work include Cancer Cells and Metastasis (14 papers), MicroRNA in disease regulation (10 papers) and Cancer Genomics and Diagnostics (7 papers). Massimo Moro is often cited by papers focused on Cancer Cells and Metastasis (14 papers), MicroRNA in disease regulation (10 papers) and Cancer Genomics and Diagnostics (7 papers). Massimo Moro collaborates with scholars based in Italy, United Kingdom and Spain. Massimo Moro's co-authors include Gabriella Sozzi, Ugo Pastorino, Luca Roz, Giulia Bertolini, Orazio Fortunato, Mattia Boeri, Maristella Mastore, Maurizio Francesco Brivio, Massimo Milione and Francesca Andriani and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Massimo Moro

39 papers receiving 1000 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Massimo Moro Italy	19	578	396	386	125	118	39	1.0k
Jianhong Zuo China	15	661 1.1×	388 1.0×	289 0.7×	106 0.8×	105 0.9×	29	1.0k
Şerif Şentürk Türkiye	16	796 1.4×	246 0.6×	295 0.8×	122 1.0×	101 0.9×	38	1.2k
Yumi Yokoyama United States	16	729 1.3×	379 1.0×	309 0.8×	186 1.5×	97 0.8×	36	1.1k
Jana Rolff Germany	14	304 0.5×	208 0.5×	350 0.9×	99 0.8×	128 1.1×	20	722
Mary L. Alpaugh United States	17	624 1.1×	347 0.9×	552 1.4×	86 0.7×	102 0.9×	28	1.2k
Xiaomei Zhang China	20	660 1.1×	360 0.9×	190 0.5×	146 1.2×	92 0.8×	38	1.0k
Zhouyu Ning China	19	500 0.9×	357 0.9×	364 0.9×	87 0.7×	134 1.1×	40	911
Guang Wu China	20	540 0.9×	273 0.7×	239 0.6×	192 1.5×	90 0.8×	48	927
Shaojie Jiang China	11	562 1.0×	196 0.5×	239 0.6×	76 0.6×	105 0.9×	16	840
Huiwei Sun China	16	388 0.7×	280 0.7×	249 0.6×	74 0.6×	80 0.7×	24	783

Countries citing papers authored by Massimo Moro

Since Specialization

Citations

This map shows the geographic impact of Massimo Moro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Moro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Moro more than expected).

Fields of papers citing papers by Massimo Moro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Moro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Moro. The network helps show where Massimo Moro may publish in the future.

Co-authorship network of co-authors of Massimo Moro

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Moro. A scholar is included among the top collaborators of Massimo Moro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Moro. Massimo Moro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moro, Massimo, Chiara Grasselli, Nicolò Panini, et al.. (2024). Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy. Journal of Experimental & Clinical Cancer Research. 43(1). 6–6. 11 indexed citations

Parodi, Monica, Giovanni Centonze, Paola Orecchia, et al.. (2024). Hybrid epithelial-mesenchymal status of lung cancer dictates metastatic success through differential interaction with NK cells. Journal for ImmunoTherapy of Cancer. 12(3). e007895–e007895. 11 indexed citations

Zulato, Elisabetta, Massimo Moro, Paola Del Bianco, et al.. (2023). Metabolic classification of non-small cell lung cancer patient-derived xenografts by a digital pathology approach: A pilot study. Frontiers in Oncology. 13. 1070505–1070505. 1 indexed citations

Borzi, Cristina, Claudia Moscheni, Patrizia Sartori, et al.. (2022). The Educational Program of Macrophages toward a Hyperprogressive Disease-Related Phenotype Is Orchestrated by Tumor-Derived Extracellular Vesicles. International Journal of Molecular Sciences. 23(24). 15802–15802. 2 indexed citations

Moro, Massimo, Orazio Fortunato, Giulia Bertolini, et al.. (2022). MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway. Pharmaceuticals. 15(3). 297–297. 19 indexed citations

Borzi, Cristina, Monica Ganzinelli, Elisa Caiola, et al.. (2021). LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress–Based Treatments. Journal of Thoracic Oncology. 16(8). 1298–1311. 16 indexed citations

Paolo, Daniela Di, Massimo Moro, Giovanni Centonze, et al.. (2021). Cotargeting of miR‐126‐3p and miR‐221‐3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signalling. Molecular Oncology. 15(11). 2969–2988. 26 indexed citations

Russo, Laura, Laura Cipolla, Massimo Moro, et al.. (2020). Differential glycosylation of collagen modulates lung cancer stem cell subsets through β1 integrin‐mediated interactions. Cancer Science. 112(1). 217–230. 32 indexed citations

Vernieri, Claudio, Monica Ganzinelli, Eliana Rulli, et al.. (2020). LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial. ESMO Open. 5(3). e000748–e000748. 5 indexed citations

10.

Moro, Massimo, Daniela Di Paolo, Massimo Milione, et al.. (2019). Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models. Journal of Controlled Release. 308. 44–56. 46 indexed citations

11.

Moro, Massimo, Elisa Caiola, Monica Ganzinelli, et al.. (2018). Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC. Journal of Thoracic Oncology. 13(11). 1692–1704. 80 indexed citations

12.

Moro, Massimo, Giulia Bertolini, Roberto Caserini, et al.. (2017). Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness. Scientific Reports. 7(1). 6689–6689. 34 indexed citations

13.

Bonanno, Laura, Angela De Paoli, Elisabetta Zulato, et al.. (2017). LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non–Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab. Clinical Cancer Research. 23(13). 3316–3324. 39 indexed citations

14.

Valtorta, Silvia, Massimo Moro, Giulia Bertolini, et al.. (2016). Metabolic Evaluation of Non–Small Cell Lung Cancer Patient–Derived Xenograft Models Using ¹⁸F-FDG PET: A Potential Tool for Early Therapy Response. Journal of Nuclear Medicine. 58(1). 42–47. 6 indexed citations

15.

Bertolini, Giulia, Lucia D’Amico, Massimo Moro, et al.. (2015). Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM− Lung Cancer–Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis. Cancer Research. 75(17). 3636–3649. 79 indexed citations

16.

Moro, Massimo, Giulia Bertolini, Ugo Pastorino, Luca Roz, & Gabriella Sozzi. (2015). Combination Treatment with All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133+ Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung Cancer. Journal of Thoracic Oncology. 10(7). 1027–1036. 34 indexed citations

17.

Andriani, Francesca, Giulia Bertolini, Federica Facchinetti, et al.. (2015). Conversion to stem‐cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells. Molecular Oncology. 10(2). 253–271. 93 indexed citations

18.

Fortunato, Orazio, Mattia Boeri, Massimo Moro, et al.. (2014). Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction. Cell Death and Disease. 5(12). e1564–e1564. 68 indexed citations

19.

Riso, Patrizia, Daniela Martini, Peter Möller, et al.. (2010). DNA damage and repair activity after broccoli intake in young healthy smokers. Mutagenesis. 25(6). 595–602. 57 indexed citations

20.

Brivio, Maurizio Francesco, Massimo Moro, & Maristella Mastore. (2005). Down-regulation of antibacterial peptide synthesis in an insect model induced by the body-surface of an entomoparasite (Steinernema feltiae). Developmental & Comparative Immunology. 30(7). 627–638. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact